Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-09-12
1980-12-16
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560121, 562503, 424319, C07C10104, A61K 31557
Patent
active
042397782
ABSTRACT:
Novel azaprostanoic acid analogs of the formula ##STR1## wherein: R is C.sub.1 to C.sub.8 alkyl or benzyl; and a has a value of from 0 to 6 inclusive, and their pharmaceutically acceptable salts and esters. Preferred 13-aza and 15-aza compounds are active in the inhibition of arachidonic acid-induced platelet aggregation and, more specifically, are direct and specific antagonists of the activity of prostaglandin H.sub.2 and thromboxane A.sub.2.
Enke Steven E.
Le Breton Guy C.
Venton Duane L.
Gerstl Robert
The University of Illinois Foundation
LandOfFree
Azaprostanoic acid analogs and their use as inhibitors of platel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaprostanoic acid analogs and their use as inhibitors of platel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaprostanoic acid analogs and their use as inhibitors of platel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-607999